1. Home
  2. PRLD vs EVI Comparison

PRLD vs EVI Comparison

Compare PRLD & EVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRLD
  • EVI
  • Stock Information
  • Founded
  • PRLD 2016
  • EVI 1959
  • Country
  • PRLD United States
  • EVI United States
  • Employees
  • PRLD N/A
  • EVI N/A
  • Industry
  • PRLD Medicinal Chemicals and Botanical Products
  • EVI Other Consumer Services
  • Sector
  • PRLD Health Care
  • EVI Consumer Discretionary
  • Exchange
  • PRLD Nasdaq
  • EVI Nasdaq
  • Market Cap
  • PRLD 110.0M
  • EVI 209.2M
  • IPO Year
  • PRLD 2020
  • EVI N/A
  • Fundamental
  • Price
  • PRLD $1.92
  • EVI $20.39
  • Analyst Decision
  • PRLD Buy
  • EVI
  • Analyst Count
  • PRLD 3
  • EVI 0
  • Target Price
  • PRLD $5.33
  • EVI N/A
  • AVG Volume (30 Days)
  • PRLD 231.0K
  • EVI 13.7K
  • Earning Date
  • PRLD 10-30-2024
  • EVI 11-07-2024
  • Dividend Yield
  • PRLD N/A
  • EVI 1.53%
  • EPS Growth
  • PRLD N/A
  • EVI N/A
  • EPS
  • PRLD N/A
  • EVI 0.37
  • Revenue
  • PRLD N/A
  • EVI $353,563,000.00
  • Revenue This Year
  • PRLD N/A
  • EVI N/A
  • Revenue Next Year
  • PRLD N/A
  • EVI N/A
  • P/E Ratio
  • PRLD N/A
  • EVI $54.14
  • Revenue Growth
  • PRLD N/A
  • EVI N/A
  • 52 Week Low
  • PRLD $1.66
  • EVI $14.51
  • 52 Week High
  • PRLD $6.80
  • EVI $27.90
  • Technical
  • Relative Strength Index (RSI)
  • PRLD 30.18
  • EVI 63.18
  • Support Level
  • PRLD $1.87
  • EVI $18.87
  • Resistance Level
  • PRLD $2.01
  • EVI $19.70
  • Average True Range (ATR)
  • PRLD 0.12
  • EVI 0.78
  • MACD
  • PRLD 0.10
  • EVI 0.01
  • Stochastic Oscillator
  • PRLD 29.41
  • EVI 100.00

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

About EVI EVI Industries Inc.

EVI Industries Inc through its subsidiaries, is a distributor that sells, leases, and rents commercial, industrial, and vended laundry and dry cleaning equipment and steam and hot water boilers manufactured by others, supplies related replacement parts and accessories, designs and plans turn-key laundry, dry cleaning, and boiler systems, and provides installation and maintenance services to its customers, which include commercial, industrial, institutional, government, and retail customers. These activities are conducted in the United States, Canada, the Caribbean and Latin America.

Share on Social Networks: